NCT00428038

Brief Summary

The purpose of this study is to evaluate how easily gas can be taken up by the lung. We are comparing infants born premature \<32 weeks gestation to infants born full term \>37 weeks. We hope to evaluate the differences between the two groups in order to learn more about premature lung growth and development.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2004

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2004

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

January 25, 2007

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 29, 2007

Completed
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2008

Completed
Last Updated

March 30, 2012

Status Verified

March 1, 2012

First QC Date

January 25, 2007

Last Update Submit

March 29, 2012

Conditions

Keywords

Infant, PrematureBronchopulmonary DysplasiaAsthma

Study Arms (3)

1

Group 1: Infants born prematurely at a gestational age \< 32 weeks with a diagnosis of chronic lung disease. Subjects will be evaluated at a corrected-age between 1 month and 24 months when they are clinically stable and free of acute respiratory symptoms for \> 3 weeks. Subjects will be excluded for the following reasons: 1. Oxygen requirements 2. Congenital heart disease

2

Group 2: Infants born prematurely at a gestational age \< 32 weeks without a diagnosis of chronic lung disease. Subjects will be evaluated at a corrected-age between 1 month and 24 months when they are clinically stable and free of acute respiratory symptoms for \> 3 weeks. Subjects will be excluded for the following reasons: 1. Oxygen requirements 2. Congenital heart disease

3

Group 3: Infants born full term at a gestational age \> 37 weeks. Subjects will be evaluated at a corrected-age between 1 month and 24 months when they are clinically stable and free of acute respiratory symptoms for \> 3 weeks. Subjects will be excluded for the following reasons: 1. Hospitalization for a respiratory illness 2. History of wheezing, asthma, or treatment with asthma medications 3. Congenital heart disease

Eligibility Criteria

Age2 Months - 2 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Recruitment for premature infants were through Infant Lung Disease clinic at Riley Hospital for Children and IU NICU. Healthy full term infants were recruited through advertisements in local newspapers.

You may qualify if:

  • Group 1 Infants born at \< 32 weeks gestation with Chronic lung disease
  • Group 2 Infants born at \<32 weeks gestation without Chronic lung disease
  • Group 3 Infants born full term at \>37 weeks

You may not qualify if:

  • Group 1 and Group 2--No heart disease, no oxygen requirement
  • Group 3--No hospitalization for respiratory illness, No asthma, No heart disease, No history of wheezing, asthma or treatment with asthma medications.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Riley Hospital for Children

Indianapolis, Indiana, 46202, United States

Location

MeSH Terms

Conditions

Premature BirthBronchopulmonary DysplasiaAsthma

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesVentilator-Induced Lung InjuryLung InjuryLung DiseasesRespiratory Tract DiseasesInfant, Premature, DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesBronchial DiseasesLung Diseases, ObstructiveRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Robert S Tepper, MD, PhD

    Indiana University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 25, 2007

First Posted

January 29, 2007

Study Start

February 1, 2004

Study Completion

December 1, 2008

Last Updated

March 30, 2012

Record last verified: 2012-03

Locations